122 related articles for article (PubMed ID: 10411578)
1. Effects of systemically administered dynorphin A(1-17) in rhesus monkeys.
Butelman ER; Harris TJ; Perez A; Kreek MJ
J Pharmacol Exp Ther; 1999 Aug; 290(2):678-86. PubMed ID: 10411578
[TBL] [Abstract][Full Text] [Related]
2. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
Butelman ER; France CP; Woods JH
J Pharmacol Exp Ther; 1995 Oct; 275(1):374-80. PubMed ID: 7562573
[TBL] [Abstract][Full Text] [Related]
3. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
Negus SS; Burke TF; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
[TBL] [Abstract][Full Text] [Related]
4. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
[TBL] [Abstract][Full Text] [Related]
5. Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys.
Butelman ER; Vivian JA; Yu J; Kreek MJ; Woods JH
Psychopharmacology (Berl); 1999 Apr; 143(2):190-6. PubMed ID: 10326782
[TBL] [Abstract][Full Text] [Related]
6. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
Stevenson GW; Folk JE; Rice KC; Negus SS
J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.
Negus SS; Gatch MB; Mello NK; Zhang X; Rice K
J Pharmacol Exp Ther; 1998 Jul; 286(1):362-75. PubMed ID: 9655881
[TBL] [Abstract][Full Text] [Related]
8. Peripheral selectivity and apparent efficacy of dynorphins: comparison to non-peptidic kappa-opioid agonists in rhesus monkeys.
Butelman ER; Ball JW; Kreek MJ
Psychoneuroendocrinology; 2004 Apr; 29(3):307-26. PubMed ID: 14644063
[TBL] [Abstract][Full Text] [Related]
9. Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys.
Butelman ER; Harris TJ; Kreek MJ
Psychopharmacology (Berl); 1999 Nov; 147(1):73-80. PubMed ID: 10591871
[TBL] [Abstract][Full Text] [Related]
10. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
Butelman ER; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Nov; 279(2):934-8. PubMed ID: 8930202
[TBL] [Abstract][Full Text] [Related]
11. Micro/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability.
Negus SS; Schrode K; Stevenson GW
Exp Clin Psychopharmacol; 2008 Oct; 16(5):386-99. PubMed ID: 18837635
[TBL] [Abstract][Full Text] [Related]
12. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
Negus SS; Mello NK
Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
[TBL] [Abstract][Full Text] [Related]
13. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation.
Brandt MR; Furness MS; Rice KC; Fischer BD; Negus SS
J Pharmacol Exp Ther; 2001 Nov; 299(2):629-37. PubMed ID: 11602675
[TBL] [Abstract][Full Text] [Related]
14. Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys.
Ko MC; Willmont KJ; Burritt A; Hruby VJ; Woods JH
Eur J Pharmacol; 2000 Aug; 402(1-2):69-76. PubMed ID: 10940359
[TBL] [Abstract][Full Text] [Related]
15. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.
Butelman ER; Winger G; Zernig G; Woods JH
J Pharmacol Exp Ther; 1995 Feb; 272(2):845-53. PubMed ID: 7853203
[TBL] [Abstract][Full Text] [Related]
16. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
17. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity.
Brandt MR; Furness MS; Mello NK; Rice KC; Negus SS
J Pharmacol Exp Ther; 2001 Mar; 296(3):939-46. PubMed ID: 11181927
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys.
Negus SS; Butelman ER; Al Y; Woods JH
J Pharmacol Exp Ther; 1993 Sep; 266(3):1355-63. PubMed ID: 8371142
[TBL] [Abstract][Full Text] [Related]
20. Chronic l-alpha-acetylmethadol (LAAM) in rhesus monkeys: tolerance and cross-tolerance to the antinociceptive, ventilatory, and rate-decreasing effects of opioids.
Brandt MR; France CP
J Pharmacol Exp Ther; 2000 Jul; 294(1):168-78. PubMed ID: 10871309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
